Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (498)	11/15/1999 8:58:00 AM
From: John Finley	Read Replies (1) \| Respond to of 645

>>Aviron Announces Delay of BLA Submission MOUNTAIN VIEW, Calif., Nov. 14 /PRNewswire/ -- Aviron (Nasdaq: AVIR), today announced that the company will not file a Biologics License Application (BLA) for FluMist(TM), its investigational influenza vaccine, with the U.S. Food and Drug Administration (FDA) in 1999. The schedule change is due to issues that arose in routine validation tests during the vaccine manufacturing process.<< The last time this happened AVIR dropped to ~12. Looking at the chart I'd say a number of folks "had a feeling" this was coming. That might blunt the impact somewhat. Opportunity's a knockin' <g> JF